Download PDF
Semin Neurol 2021; 41(05): 554-571
DOI: 10.1055/s-0041-1733795
Review Article

Approach to Neurologic Complications in the Immunocompromised Patient

Anastasia Vishnevetsky
1   Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
2   Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
,
Pria Anand 
3   Department of Neurology, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts
› Author Affiliations Funding None.
› Further Information
    Permissions and Reprints

Abstract

Neurologic complications are common in immunocompromised patients, including those with advanced human immunodeficiency virus, transplant recipients, and patients on immunomodulatory medications. In addition to the standard differential diagnosis, specific pathogens and other conditions unique to the immunocompromised state should be considered in the evaluation of neurologic complaints in this patient population. A thorough understanding of these considerations is critical to the inpatient neurologist in contemporary practice, as increasing numbers of patients are exposed to immunomodulatory therapies. In this review, we provide a chief complaint-based approach to the clinical presentations and diagnosis of both infectious and noninfectious complications particular to immunocompromised patients.

Keywords

neuroinfectious diseases - immunocompromised - HIV - transplant


Publication History

Article published online:
07 October 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Graus F, Saiz A, Sierra J. et al. Neurologic complications of autologous and allogeneic bone marrow transplantation in patients with leukemia: a comparative study. Neurology 1996; 46 (04) 1004-1009
    CrossrefPubMedGoogle Scholar
  • 2 Dowling MR, Li S, Dey BR. et al. Neurologic complications after allogeneic hematopoietic stem cell transplantation: risk factors and impact. Bone Marrow Transplant 2018; 53 (02) 199-206
    CrossrefPubMedGoogle Scholar
  • 3 Senzolo M, Ferronato C, Burra P. Neurologic complications after solid organ transplantation. Transpl Int 2009; 22 (03) 269-278
    CrossrefPubMedGoogle Scholar
  • 4 Goldstein LS, Haug III MT, Perl II J. et al. Central nervous system complications after lung transplantation. J Heart Lung Transplant 1998; 17 (02) 185-191
    PubMedGoogle Scholar
  • 5 Lewis MB, Howdle PD. Neurologic complications of liver transplantation in adults. Neurology 2003; 61 (09) 1174-1178
    CrossrefPubMedGoogle Scholar
  • 6 Watanabe K, Arakawa Y, Oguma E. et al. Characteristics of methotrexate-induced stroke-like neurotoxicity. Int J Hematol 2018; 108 (06) 630-636
    CrossrefPubMedGoogle Scholar
  • 7 Zhang W, Egashira N, Masuda S. Recent topics on the mechanisms of immunosuppressive therapy-related neurotoxicities. Int J Mol Sci 2019; 20 (13) E3210
    CrossrefPubMedGoogle Scholar
  • 8 Pruitt AA. Neurologic complications of transplantation. Continuum (Minneap Minn) 2017; 23 (3, Neurology of Systemic Disease): 802-821
    PubMedGoogle Scholar
  • 9 Tan IL, Smith BR, von Geldern G, Mateen FJ, McArthur JC. HIV-associated opportunistic infections of the CNS. Lancet Neurol 2012; 11 (07) 605-617
    CrossrefPubMedGoogle Scholar
  • 10 Wong MC, Suite NDA, Labar DR. Seizures in human immunodeficiency virus infection. Arch Neurol 1990; 47 (06) 640-642
    CrossrefPubMedGoogle Scholar
  • 11 Wilson MR, Sample HA, Zorn KC. et al. Clinical metagenomic sequencing for diagnosis of meningitis and encephalitis. N Engl J Med 2019; 380 (24) 2327-2340
    CrossrefPubMedGoogle Scholar
  • 12 Wilson MR, Naccache SN, Samayoa E. et al. Actionable diagnosis of neuroleptospirosis by next-generation sequencing. N Engl J Med 2014; 370 (25) 2408-2417
    CrossrefPubMedGoogle Scholar
  • 13 Sato M, Kuroda M, Kasai M. et al. Acute encephalopathy in an immunocompromised boy with astrovirus-MLB1 infection detected by next generation sequencing. J Clin Virol 2016; 78: 66-70
    CrossrefPubMedGoogle Scholar
  • 14 Hu Z, Weng X, Xu C. et al. Metagenomic next-generation sequencing as a diagnostic tool for toxoplasmic encephalitis. Ann Clin Microbiol Antimicrob 2018; 17 (01) 45
    CrossrefPubMedGoogle Scholar
  • 15 Yao M, Zhou J, Zhu Y. et al. Detection of Listeria monocytogenes in CSF from three patients with meningoencephalitis by next-generation sequencing. J Clin Neurol 2016; 12 (04) 446-451
    CrossrefPubMedGoogle Scholar
  • 16 Reddy SM, Winston DJ, Territo MC, Schiller GJ. CMV central nervous system disease in stem-cell transplant recipients: an increasing complication of drug-resistant CMV infection and protracted immunodeficiency. Bone Marrow Transplant 2010; 45 (06) 979-984
    CrossrefPubMedGoogle Scholar
  • 17 Wolf DG, Lurain NS, Zuckerman T. et al. Emergence of late cytomegalovirus central nervous system disease in hematopoietic stem cell transplant recipients. Blood 2003; 101 (02) 463-465
    CrossrefPubMedGoogle Scholar
  • 18 Anders H-J, Goebel FD. Neurological manifestations of cytomegalovirus infection in the acquired immunodeficiency syndrome. Int J STD AIDS 1999; 10 (03) 151-159 , quiz 160–161
    CrossrefPubMedGoogle Scholar
  • 19 Sarva H, Graber J, Remanan R, Rosenblum M, Omuro A. CMV encephalitis in BMT recipients. Bone Marrow Transplant 2012; 47 (02) 318-320
    CrossrefPubMedGoogle Scholar
  • 20 Maschke M, Kastrup O, Diener H-C. CNS manifestations of cytomegalovirus infections: diagnosis and treatment. CNS Drugs 2002; 16 (05) 303-315
    CrossrefPubMedGoogle Scholar
  • 21 Arribas JR, Clifford DB, Fichtenbaum CJ, Commins DL, Powderly WG, Storch GA. Level of cytomegalovirus (CMV) DNA in cerebrospinal fluid of subjects with AIDS and CMV infection of the central nervous system. J Infect Dis 1995; 172 (02) 527-531
    CrossrefPubMedGoogle Scholar
  • 22 Seeley WW, Marty FM, Holmes TM. et al. Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6. Neurology 2007; 69 (02) 156-165
    CrossrefPubMedGoogle Scholar
  • 23 Zerr DM, Fann JR, Breiger D. et al. HHV-6 reactivation and its effect on delirium and cognitive functioning in hematopoietic cell transplantation recipients. Blood 2011; 117 (19) 5243-5249
    CrossrefPubMedGoogle Scholar
  • 24 Shiroshita K, Mori T, Kato J. et al. Clinical characteristics of human herpesvirus-6 myelitis after allogeneic hematopoietic stem cell transplantation and its favorable outcome by early intervention. Bone Marrow Transplant 2020; 55 (05) 939-945
    CrossrefPubMedGoogle Scholar
  • 25 Ogata M, Oshima K, Ikebe T. et al. Clinical characteristics and outcome of human herpesvirus-6 encephalitis after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2017; 52 (11) 1563-1570
    CrossrefPubMedGoogle Scholar
  • 26 Ogata M, Fukuda T, Teshima T. Human herpesvirus-6 encephalitis after allogeneic hematopoietic cell transplantation: what we do and do not know. Bone Marrow Transplant 2015; 50 (08) 1030-1036
    CrossrefPubMedGoogle Scholar
  • 27 Victoria NC, Phan TL, Agarwal KA. A systematic review of sodium disorders in HHV-6 encephalitis. Biol Blood Marrow Transplant 2020; 26 (05) 1034-1039
    CrossrefPubMedGoogle Scholar
  • 28 Bhanushali MJ, Kranick SM, Freeman AF. et al. Human herpes 6 virus encephalitis complicating allogeneic hematopoietic stem cell transplantation. Neurology 2013; 80 (16) 1494-1500
    CrossrefPubMedGoogle Scholar
  • 29 Ogata M, Satou T, Kadota J. et al. Human herpesvirus 6 (HHV-6) reactivation and HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: a multicenter, prospective study. Clin Infect Dis 2013; 57 (05) 671-681
    CrossrefPubMedGoogle Scholar
  • 30 Vinnard C, Barton T, Jerud E, Blumberg E. A report of human herpesvirus 6-associated encephalitis in a solid organ transplant recipient and a review of previously published cases. Liver Transpl 2009; 15 (10) 1242-1246
    CrossrefPubMedGoogle Scholar
  • 31 Astriti M, Zeller V, Boutolleau D. et al. Fatal HHV-6 associated encephalitis in an HIV-1 infected patient treated with cidofovir. J Infect 2006; 52 (04) 237-242
    CrossrefPubMedGoogle Scholar
  • 32 Berzero G, Di Stefano AL, Dehais C. et al. Herpes simplex encephalitis in glioma patients: a challenging diagnosis. J Neurol Neurosurg Psychiatry 2015; 86 (04) 374-377
    CrossrefPubMedGoogle Scholar
  • 33 Schiff D, Rosenblum MK. Herpes simplex encephalitis (HSE) and the immunocompromised: a clinical and autopsy study of HSE in the settings of cancer and human immunodeficiency virus-type 1 infection. Hum Pathol 1998; 29 (03) 215-222
    CrossrefPubMedGoogle Scholar
  • 34 Saylor D, Thakur K, Venkatesan A. Acute encephalitis in the immunocompromised individual. Curr Opin Infect Dis 2015; 28 (04) 330-336
    CrossrefPubMedGoogle Scholar
  • 35 Haneche F, Demeret S, Psimaras D, Katlama C, Pourcher V. An anti-NMDA receptor encephalitis mimicking an HIV encephalitis. Clin Immunol 2018; 193: 10-11
    CrossrefPubMedGoogle Scholar
  • 36 Arboleya S, Clemente A, Deng S. et al. Anti-NMDAR antibodies in new-onset psychosis. Positive results in an HIV-infected patient. Brain Behav Immun 2016; 56: 56-60
    CrossrefPubMedGoogle Scholar
  • 37 Patarata E, Bernardino V, Martins A, Pereira R, Loureiro C, Moraes-Fontes MF. Anti-N-methyl-D-aspartate receptor encephalitis in HIV infection. Case Rep Neurol 2016; 8 (03) 251-257
    CrossrefPubMedGoogle Scholar
  • 38 Cohen DA, Lopez-Chiriboga AS, Pittock SJ. et al. Posttransplant autoimmune encephalitis. Neurol Neuroimmunol Neuroinflamm 2018; 5 (06) e497
    CrossrefPubMedGoogle Scholar
  • 39 Chittick P, Williamson JC, Ohl CA. BK virus encephalitis: case report, review of the literature, and description of a novel treatment modality. Ann Pharmacother 2013; 47 (09) 1229-1233
    CrossrefPubMedGoogle Scholar
  • 40 Hirsch HH, Steiger J. Polyomavirus BK. Lancet Infect Dis 2003; 3 (10) 611-623
    CrossrefPubMedGoogle Scholar
  • 41 Kalra SK, Sharma P, Shyam K, Tejan N, Ghoshal U. Acanthamoeba and its pathogenic role in granulomatous amebic encephalitis. Exp Parasitol 2020; 208: 107788
    CrossrefPubMedGoogle Scholar
  • 42 Gonzalez MM, Gould E, Dickinson G. et al. Acquired immunodeficiency syndrome associated with Acanthamoeba infection and other opportunistic organisms. Arch Pathol Lab Med 1986; 110 (08) 749-751
    PubMedGoogle Scholar
  • 43 Geith S, Walochnik J, Prantl F, Sack S, Eyer F. Lethal outcome of granulomatous acanthamoebic encephalitis in a man who was human immunodeficiency virus-positive: a case report. J Med Case Reports 2018; 12 (01) 201
    CrossrefPubMedGoogle Scholar
  • 44 Vernon SE, Acar BC, Pham SM, Fertel D. Acanthamoeba infection in lung transplantation: report of a case and review of the literature. Transpl Infect Dis 2005; 7 (3-4): 154-157
    CrossrefPubMedGoogle Scholar
  • 45 Crothers JW, Hsu L, Marty FM. Fulminant Acanthamoeba castellanii encephalitis in an ibrutinib-treated patient. Open Forum Infect Dis 2020; 7 (02) a025
    CrossrefPubMedGoogle Scholar
  • 46 Schlessinger S, Kokko K, Fratkin J. et al; Centers for Disease Control and Prevention (CDC). Balamuthia mandrillaris transmitted through organ transplantation–Mississippi, 2009. MMWR Morb Mortal Wkly Rep 2010; 59 (36) 1165-1170
    PubMedGoogle Scholar
  • 47 Itoh K, Yagita K, Nozaki T. et al. An autopsy case of Balamuthia mandrillaris amoebic encephalitis, a rare emerging infectious disease, with a brief review of the cases reported in Japan. Neuropathology 2015; 35 (01) 64-69
    CrossrefPubMedGoogle Scholar
  • 48 Deetz TR, Sawyer MH, Billman G, Schuster FL, Visvesvara GS. Successful treatment of Balamuthia amoebic encephalitis: presentation of 2 cases. Clin Infect Dis 2003; 37 (10) 1304-1312
    CrossrefPubMedGoogle Scholar
  • 49 Parija SC, Dinoop K, Venugopal H. Management of granulomatous amebic encephalitis: laboratory diagnosis and treatment. Trop Parasitol 2015; 5 (01) 23-28
    CrossrefPubMedGoogle Scholar
  • 50 Schumacher DJ, Tien RD, Lane K. Neuroimaging findings in rare amebic infections of the central nervous system. AJNR Am J Neuroradiol 1995; 16 (4, Suppl): 930-935
    PubMedGoogle Scholar
  • 51 McArthur JC, Hoover DR, Bacellar H. et al. Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study. Neurology 1993; 43 (11) 2245-2252
    CrossrefPubMedGoogle Scholar
  • 52 Saylor D, Dickens AM, Sacktor N. et al. HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment. Nat Rev Neurol 2016; 12 (04) 234-248
    CrossrefPubMedGoogle Scholar
  • 53 Nagel MA, Cohrs RJ, Mahalingam R. et al. The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features. Neurology 2008; 70 (11) 853-860
    CrossrefPubMedGoogle Scholar
  • 54 Nagel MA, Bubak AN. Varicella zoster virus vasculopathy. J Infect Dis 2018; 218 (Suppl. 02) S107-S112
    CrossrefPubMedGoogle Scholar
  • 55 Nagel MA, Gilden D. Neurological complications of VZV reactivation. Curr Opin Neurol 2014; 27 (03) 356-360
    CrossrefPubMedGoogle Scholar
  • 56 Moses H, Nagel MA, Gilden DH. Acute cerebellar ataxia in a 41 year old woman. Lancet Neurol 2006; 5 (11) 984-988
    CrossrefPubMedGoogle Scholar
  • 57 Issa NP, Hentati A. VZV encephalitis that developed in an immunized patient during fingolimod therapy. Neurology 2015; 84 (01) 99-100
    CrossrefPubMedGoogle Scholar
  • 58 Tizazu EF, Chang G, Berger JR. Varicella zoster virus (VZV) oculomeningoencephalomyeloradiculitis: a previously undescribed constellation. J Neurovirol 2020; 26 (03) 433-436
    CrossrefPubMedGoogle Scholar
  • 59 Gunson RN, Aitken C, Gilden D. A woman with acute headache and sacral dermatomal numbness. J Clin Virol 2011; 50 (03) 191-193
    CrossrefPubMedGoogle Scholar
  • 60 Bhagat RK, Zieske AW, Kamble RT. Cerebrospinal leukemoid reaction secondary to VZV meninigoencephalitis in an AML patient post allogeneic bone marrow transplantation. Blood 2013; 122 (02) 300-301
    CrossrefPubMedGoogle Scholar
  • 61 Habib AA, Gilden D, Schmid DS, Safdieh JE. Varicella zoster virus meningitis with hypoglycorrhachia in the absence of rash in an immunocompetent woman. J Neurovirol 2009; 15 (02) 206-208
    CrossrefPubMedGoogle Scholar
  • 62 Ma M, Barnes G, Pulliam J, Jezek D, Baumann RJ, Berger JR. CNS angiitis in graft vs host disease. Neurology 2002; 59 (12) 1994-1997
    CrossrefPubMedGoogle Scholar
  • 63 Sostak P, Padovan CS, Eigenbrod S. et al. Cerebral angiitis in four patients with chronic GVHD. Bone Marrow Transplant 2010; 45 (07) 1181-1188
    CrossrefPubMedGoogle Scholar
  • 64 Pahari H, Nagai S, Skorupski S, Salgia R. Graft-versus-host disease of the central nervous system after liver transplantation: a rare complication. Am J Transplant 2018; 18 (10) 2591-2594
    CrossrefPubMedGoogle Scholar
  • 65 Kamble RT, Chang C-C, Sanchez S, Carrum G. Central nervous system graft-versus-host disease: report of two cases and literature review. Bone Marrow Transplant 2007; 39 (01) 49-52
    CrossrefPubMedGoogle Scholar
  • 66 Blasiak KP, Simonetta F, Vargas M-I, Chalandon Y. Central nervous system graft-versus-host disease (CNS-GvHD) after allogeneic haematopoietic stem cell transplantation. BMJ Case Rep 2018; 2018 :bcr-2017 221840
    PubMedGoogle Scholar
  • 67 Porter SB, Sande MA. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med 1992; 327 (23) 1643-1648
    CrossrefPubMedGoogle Scholar
  • 68 Robert-Gangneux F, Meroni V, Dupont D. et al. Toxoplasmosis in transplant recipients, Europe, 2010-2014. Emerg Infect Dis 2018; 24 (08) 1497-1504
    CrossrefPubMedGoogle Scholar
  • 69 Hakko E, Ozkan HA, Karaman K, Gulbas Z. Analysis of cerebral toxoplasmosis in a series of 170 allogeneic hematopoietic stem cell transplant patients. Transpl Infect Dis 2013; 15 (06) 575-580
    CrossrefPubMedGoogle Scholar
  • 70 Nath A, Hobson DE, Russell A. Movement disorders with cerebral toxoplasmosis and AIDS. Mov Disord 1993; 8 (01) 107-112
    CrossrefPubMedGoogle Scholar
  • 71 Smith AB, Smirniotopoulos JG, Rushing EJ. From the archives of the AFIP: central nervous system infections associated with human immunodeficiency virus infection: radiologic-pathologic correlation. Radiographics 2008; 28 (07) 2033-2058
    CrossrefPubMedGoogle Scholar
  • 72 Marra CM. Central nervous system infection with Toxoplasma gondii . Handb Clin Neurol 2018; 152: 117-122
    CrossrefPubMedGoogle Scholar
  • 73 Benson JC, Cervantes G, Baron TR. et al. Imaging features of neurotoxoplasmosis: a multiparametric approach, with emphasis on susceptibility-weighted imaging. Eur J Radiol Open 2018; 5: 45-51
    CrossrefPubMedGoogle Scholar
  • 74 Kumar GGS, Mahadevan A, Guruprasad AS. et al. Eccentric target sign in cerebral toxoplasmosis: neuropathological correlate to the imaging feature. J Magn Reson Imaging 2010; 31 (06) 1469-1472
    CrossrefPubMedGoogle Scholar
  • 75 Bhagavati S, Choi J. Frequent hemorrhagic lesions in cerebral toxoplasmosis in AIDS patients. J Neuroimaging 2009; 19 (02) 169-173
    CrossrefPubMedGoogle Scholar
  • 76 Belaz S, Gangneux J-P, Dupretz P, Guiguen C, Robert-Gangneux F. A 10-year retrospective comparison of two target sequences, REP-529 and B1, for Toxoplasma gondii detection by quantitative PCR. J Clin Microbiol 2015; 53 (04) 1294-1300
    CrossrefPubMedGoogle Scholar
  • 77 Yu GH, Montone KT, Frias-Hidvegi D, Cajulis RS, Brody BA, Levy RM. Cytomorphology of primary CNS lymphoma: review of 23 cases and evidence for the role of EBV. Diagn Cytopathol 1996; 14 (02) 114-120
    CrossrefPubMedGoogle Scholar
  • 78 Herndier BG, Kaplan LD, McGrath MS. Pathogenesis of AIDS lymphomas. AIDS 1994; 8 (08) 1025-1049
    CrossrefPubMedGoogle Scholar
  • 79 Yang M, Sun J, Bai HX. et al. Diagnostic accuracy of SPECT, PET, and MRS for primary central nervous system lymphoma in HIV patients: a systematic review and meta-analysis. Medicine (Baltimore) 2017; 96 (19) e6676
    CrossrefPubMedGoogle Scholar
  • 80 Grimm SA, McCannel CA, Omuro AMP. et al. Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report. Neurology 2008; 71 (17) 1355-1360
    CrossrefPubMedGoogle Scholar
  • 81 Weller M. Glucocorticoid treatment of primary CNS lymphoma. J Neurooncol 1999; 43 (03) 237-239
    CrossrefPubMedGoogle Scholar
  • 82 Evens AM, Choquet S, Kroll-Desrosiers AR. et al. Primary CNS posttransplant lymphoproliferative disease (PTLD): an international report of 84 cases in the modern era. Am J Transplant 2013; 13 (06) 1512-1522
    CrossrefPubMedGoogle Scholar
  • 83 Cavaliere R, Petroni G, Lopes MB, Schiff D. International Primary Central Nervous System Lymphoma Collaborative Group. Primary central nervous system post-transplantation lymphoproliferative disorder: an International Primary Central Nervous System Lymphoma Collaborative Group Report. Cancer 2010; 116 (04) 863-870
    CrossrefPubMedGoogle Scholar
  • 84 White ML, Moore DW, Zhang Y, Mark KD, Greiner TC, Bierman PJ. Primary central nervous system post-transplant lymphoproliferative disorders: the spectrum of imaging appearances and differential. Insights Imaging 2019; 10 (01) 46
    CrossrefPubMedGoogle Scholar
  • 85 Whitehead MT, Cardenas AM, Corey AS. et al; Expert Panel on Neurologic Imaging. ACR Appropriateness Criteria® Headache. J Am Coll Radiol 2019; 16 (11S): S364-S377
    CrossrefPubMedGoogle Scholar
  • 86 Brouwer MC, Tunkel AR, McKhann II GM, van de Beek D. Brain abscess. N Engl J Med 2014; 371 (05) 447-456
    CrossrefPubMedGoogle Scholar
  • 87 Patterson TF, Kirkpatrick WR, White M. et al. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group. Medicine (Baltimore) 2000; 79 (04) 250-260
    Google Scholar
  • 88 Ruhnke M, Kofla G, Otto K, Schwartz S. CNS aspergillosis: recognition, diagnosis and management. CNS Drugs 2007; 21 (08) 659-676
    CrossrefPubMedGoogle Scholar
  • 89 Boes B, Bashir R, Boes C, Hahn F, McConnell JR, McComb R. Central nervous system aspergillosis. Analysis of 26 patients. J Neuroimaging 1994; 4 (03) 123-129
    CrossrefPubMedGoogle Scholar
  • 90 Jantunen E, Volin L, Salonen O. et al. Central nervous system aspergillosis in allogeneic stem cell transplant recipients. Bone Marrow Transplant 2003; 31 (03) 191-196
    CrossrefPubMedGoogle Scholar
  • 91 Walsh TJ, Hier DB, Caplan LR. Aspergillosis of the central nervous system: clinicopathological analysis of 17 patients. Ann Neurol 1985; 18 (05) 574-582
    CrossrefPubMedGoogle Scholar
  • 92 Guermazi A, Gluckman E, Tabti B, Miaux Y. Invasive central nervous system aspergillosis in bone marrow transplantation recipients: an overview. Eur Radiol 2003; 13 (02) 377-388
    CrossrefPubMedGoogle Scholar
  • 93 Chong GM, Maertens JA, Lagrou K, Driessen GJ, Cornelissen JJ, Rijnders BJA. Diagnostic performance of galactomannan antigen testing in cerebrospinal fluid. J Clin Microbiol 2016; 54 (02) 428-431
    CrossrefPubMedGoogle Scholar
  • 94 Imbert S, Brossas JY, Palous M, Joly I, Meyer I, Fekkar A. Performance of Aspergillus PCR in cerebrospinal fluid for the diagnosis of cerebral aspergillosis. Clin Microbiol Infect 2017; 23 (11) 889.e1-889.e4
    CrossrefPubMedGoogle Scholar
  • 95 Sánchez-Portocarrero J, Pérez-Cecilia E, Corral O, Romero-Vivas J, Picazo JJ. The central nervous system and infection by Candida species. Diagn Microbiol Infect Dis 2000; 37 (03) 169-179
    CrossrefPubMedGoogle Scholar
  • 96 Moran CA, Terry C, Nguyen MLT, Sheth AN. Use of cerebrospinal fluid (1,3)-β-D-glucan to monitor treatment response in Candida albicans meningitis in an HIV-infected patient. Infect Dis Clin Pract 2018; 26 (06) e70
    CrossrefPubMedGoogle Scholar
  • 97 Anagnostou T, Arvanitis M, Kourkoumpetis TK, Desalermos A, Carneiro HA, Mylonakis E. Nocardiosis of the central nervous system: experience from a general hospital and review of 84 cases from the literature. Medicine (Baltimore) 2014; 93 (01) 19-32
    CrossrefPubMedGoogle Scholar
  • 98 Steinbrink J, Leavens J, Kauffman CA, Miceli MH. Manifestations and outcomes of Nocardia infections: comparison of immunocompromised and nonimmunocompromised adult patients. Medicine (Baltimore) 2018; 97 (40) e12436
    CrossrefPubMedGoogle Scholar
  • 99 Rafiei N, Peri AM, Righi E, Harris P, Paterson DL. Central nervous system nocardiosis in Queensland: a report of 20 cases and review of the literature. Medicine (Baltimore) 2016; 95 (46) e5255
    CrossrefPubMedGoogle Scholar
  • 100 Gertz K, Siebert E, Halle E. et al. Multiple supratentorial brain abscesses due to Listeria monocytogenes in a patient with myasthenia gravis. Clin Neurol Neurosurg 2013; 115 (09) 1923-1924
    CrossrefPubMedGoogle Scholar
  • 101 Berry AC, Nguyen L, Yarbrough T, Iqbal F, Green WK. Ring-enhancing brain lesions: Listeria monocytogenes abscesses. Intern Emerg Med 2016; 11 (05) 763-765
    CrossrefPubMedGoogle Scholar
  • 102 Mathisen GE, Johnson JP. Brain abscess. Clin Infect Dis 1997; 25 (04) 763-779 , quiz 780–781
    CrossrefPubMedGoogle Scholar
  • 103 Limmahakhun S, Chayakulkeeree M. Listeria monocytogenes brain abscess: two cases and review of the literature. Southeast Asian J Trop Med Public Health 2013; 44 (03) 468-478
    PubMedGoogle Scholar
  • 104 Tiri B, Priante G, Saraca LM, Martella LA, Cappanera S, Francisci D. Listeria monocytogenes brain abscess: controversial issues for the treatment-two cases and literature review. Case Rep Infect Dis 2018; 2018: 6549496
    PubMedGoogle Scholar
  • 105 Rai S, Marak RSK, Jain S, Dhole TN. Posterior fossa midline cryptococcoma in a patient with idiopathic CD4 lymphocytopenia. Indian J Med Microbiol 2012; 30 (03) 367-370
    CrossrefPubMedGoogle Scholar
  • 106 Williamson PR, Jarvis JN, Panackal AA. et al. Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy. Nat Rev Neurol 2017; 13 (01) 13-24
    CrossrefPubMedGoogle Scholar
  • 107 Shih CC, Chen YC, Chang SC, Luh KT, Hsieh WC. Cryptococcal meningitis in non-HIV-infected patients. QJM 2000; 93 (04) 245-251
    CrossrefPubMedGoogle Scholar
  • 108 Fang W, Chen M, Liu J. et al. Cryptococcal meningitis in systemic lupus erythematosus patients: pooled analysis and systematic review. Emerg Microbes Infect 2016; 5 (09) e95
    PubMedGoogle Scholar
  • 109 Meyohas M-C, Roux P, Bollens D. et al. Pulmonary cryptococcosis: localized and disseminated infections in 27 patients with AIDS. Clin Infect Dis 1995; 21 (03) 628-633
    CrossrefPubMedGoogle Scholar
  • 110 Dimino-Emme L, Gurevitch AW. Cutaneous manifestations of disseminated cryptococcosis. J Am Acad Dermatol 1995; 32 (5, Pt 2): 844-850
    CrossrefPubMedGoogle Scholar
  • 111 Graybill JR, Sobel J, Saag M. et al; The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups. Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. Clin Infect Dis 2000; 30 (01) 47-54
    CrossrefPubMedGoogle Scholar
  • 112 Feldmesser M, Harris C, Reichberg S, Khan S, Casadevall A. Serum cryptococcal antigen in patients with AIDS. Clin Infect Dis 1996; 23 (04) 827-830
    CrossrefPubMedGoogle Scholar
  • 113 Boulware DR, Rolfes MA, Rajasingham R. et al. Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrast. Emerg Infect Dis 2014; 20 (01) 45-53
    CrossrefPubMedGoogle Scholar
  • 114 Charlier C, Dromer F, Lévêque C. et al; French Cryptococcosis Study Group. Cryptococcal neuroradiological lesions correlate with severity during cryptococcal meningoencephalitis in HIV-positive patients in the HAART era. PLoS One 2008; 3 (04) e1950
    CrossrefPubMedGoogle Scholar
  • 115 Sarkis RA, Mays M, Isada C, Ahmed M. MRI findings in cryptococcal meningitis of the non-HIV population. Neurologist 2015; 19 (02) 40-45
    CrossrefPubMedGoogle Scholar
  • 116 Tien RD, Chu PK, Hesselink JR, Duberg A, Wiley C. Intracranial cryptococcosis in immunocompromised patients: CT and MR findings in 29 cases. AJNR Am J Neuroradiol 1991; 12 (02) 283-289
    PubMedGoogle Scholar
  • 117 Starkey J, Moritani T, Kirby P. MRI of CNS fungal infections: review of aspergillosis to histoplasmosis and everything in between. Clin Neuroradiol 2014; 24 (03) 217-230
    CrossrefPubMedGoogle Scholar
  • 118 Subramanian A, Dorman S. AST Infectious Diseases Community of Practice. Mycobacterium tuberculosis in solid organ transplant recipients. Am J Transplant 2009; 9 (Suppl. 04) S57-S62
    CrossrefPubMedGoogle Scholar
  • 119 Keane J, Gershon S, Wise RP. et al. Tuberculosis associated with infliximab, a tumor necrosis factor α-neutralizing agent. N Engl J Med 2001; 345 (15) 1098-1104
    CrossrefPubMedGoogle Scholar
  • 120 Marais S, Pepper DJ, Schutz C, Wilkinson RJ, Meintjes G. Presentation and outcome of tuberculous meningitis in a high HIV prevalence setting. PLoS One 2011; 6 (05) e20077
    CrossrefPubMedGoogle Scholar
  • 121 Kent SJ, Crowe SM, Yung A, Lucas CR, Mijch AM. Tuberculous meningitis: a 30-year review. Clin Infect Dis 1993; 17 (06) 987-994
    CrossrefPubMedGoogle Scholar
  • 122 Davis LE, Rastogi KR, Lambert LC, Skipper BJ. Tuberculous meningitis in the southwest United States: a community-based study. Neurology 1993; 43 (09) 1775-1778
    CrossrefPubMedGoogle Scholar
  • 123 Verdon R, Chevret S, Laissy JP, Wolff M. Tuberculous meningitis in adults: review of 48 cases. Clin Infect Dis 1996; 22 (06) 982-988
    CrossrefPubMedGoogle Scholar
  • 124 Farinha NJ, Razali KA, Holzel H, Morgan G, Novelli VM. Tuberculosis of the central nervous system in children: a 20-year survey. J Infect 2000; 41 (01) 61-68
    CrossrefPubMedGoogle Scholar
  • 125 Girgis NI, Sultan Y, Farid Z. et al. Tuberculosis meningitis, Abbassia Fever Hospital-Naval Medical Research Unit No. 3-Cairo, Egypt, from 1976 to 1996. Am J Trop Med Hyg 1998; 58 (01) 28-34
    CrossrefPubMedGoogle Scholar
  • 126 Misra UK, Kumar M, Kalita J. Seizures in tuberculous meningitis. Epilepsy Res 2018; 148: 90-95
    CrossrefPubMedGoogle Scholar
  • 127 Thwaites GE, Tran TH. Tuberculous meningitis: many questions, too few answers. Lancet Neurol 2005; 4 (03) 160-170
    CrossrefPubMedGoogle Scholar
  • 128 Hosoğlu S, Ayaz C, Geyik MF, Kökoğlu OF, Ceviz A. Tuberculous meningitis in adults: an eleven-year review. Int J Tuberc Lung Dis 1998; 2 (07) 553-557
    PubMedGoogle Scholar
  • 129 Misra UK, Kalita J, Bhoi SK, Singh RK. A study of hyponatremia in tuberculous meningitis. J Neurol Sci 2016; 367: 152-157
    CrossrefPubMedGoogle Scholar
  • 130 Kalita J, Misra UK, Nair PP. Predictors of stroke and its significance in the outcome of tuberculous meningitis. J Stroke Cerebrovasc Dis 2009; 18 (04) 251-258
    CrossrefPubMedGoogle Scholar
  • 131 Wasay M, Khan M, Farooq S. et al. Frequency and impact of cerebral infarctions in patients with tuberculous meningitis. Stroke 2018; 49 (10) 2288-2293
    CrossrefPubMedGoogle Scholar
  • 132 Alarcón F, Dueñas G, Cevallos N, Lees AJ. Movement disorders in 30 patients with tuberculous meningitis. Mov Disord 2000; 15 (03) 561-569
    CrossrefPubMedGoogle Scholar
  • 133 Nhu NTQ, Heemskerk D, Thu DA. et al. Evaluation of GeneXpert MTB/RIF for diagnosis of tuberculous meningitis. J Clin Microbiol 2014; 52 (01) 226-233
    CrossrefPubMedGoogle Scholar
  • 134 Garg RK, Malhotra HS, Jain A. Neuroimaging in tuberculous meningitis. Neurol India 2016; 64 (02) 219-227
    CrossrefPubMedGoogle Scholar
  • 135 Wasay M, Arif H, Khealani B, Ahsan H. Neuroimaging of tuberculous myelitis: analysis of ten cases and review of literature. J Neuroimaging 2006; 16 (03) 197-205
    CrossrefPubMedGoogle Scholar
  • 136 Mylonakis E, Hohmann EL, Calderwood SB. Central nervous system infection with Listeria monocytogenes. 33 years' experience at a general hospital and review of 776 episodes from the literature. Medicine (Baltimore) 1998; 77 (05) 313-336
    CrossrefPubMedGoogle Scholar
  • 137 Dzupova O, Rozsypal H, Smiskova D, Benes J. Listeria monocytogenes meningitis in adults: the Czech Republic experience. BioMed Res Int 2013; 2013: 846186
    CrossrefPubMedGoogle Scholar
  • 138 Dee RR, Lorber B. Brain abscess due to Listeria monocytogenes: case report and literature review. Rev Infect Dis 1986; 8 (06) 968-977
    CrossrefPubMedGoogle Scholar
  • 139 Carmo RLD, Alves Simão AK, Amaral LLFD. et al. Neuroimaging of emergent and reemergent infections. Radiographics 2019; 39 (06) 1649-1671
    CrossrefPubMedGoogle Scholar
  • 140 Chong J, Di Rocco A, Tagliati M, Danisi F, Simpson DM, Atlas SW. MR findings in AIDS-associated myelopathy. AJNR Am J Neuroradiol 1999; 20 (08) 1412-1416
    PubMedGoogle Scholar
  • 141 Wang Y, Yu CY, Huang L, Han YY, Liu YM, Zhu J. Acute longitudinal and hemorrhagic myelitis caused by varicella-zoster virus in an immunocompetent adolescent. Neurologist 2015; 19 (04) 93-95
    CrossrefPubMedGoogle Scholar
  • 142 Bourre B, Lefaucheur R, Ahtoy P, Travers F, Fetter D. Varicella-zoster virus acute myelitis in a patient with MS treated with natalizumab. Neurology 2013; 81 (22) 1966-1967
    CrossrefPubMedGoogle Scholar
  • 143 Cuello JP, Romero J, de Ory F, de Andrés C. Longitudinally extensive varicella-zoster virus myelitis in a patient with multiple sclerosis. Spine 2013; 38 (20) E1282-E1284
    CrossrefPubMedGoogle Scholar
  • 144 Hernández-Albújar S, Arribas JR, Royo A, González-García JJ, Peña JM, Vázquez JJ. Tuberculous radiculomyelitis complicating tuberculous meningitis: case report and review. Clin Infect Dis 2000; 30 (06) 915-921
    CrossrefPubMedGoogle Scholar
  • 145 Marais S, Roos I, Mitha A, Mabusha SJ, Patel V, Bhigjee AI. Spinal tuberculosis: clinicoradiological findings in 274 patients. Clin Infect Dis 2018; 67 (01) 89-98
    CrossrefPubMedGoogle Scholar
  • 146 Goldstein J, Dangayach N, Riley D. An almost crypto(genic) cause of radiculopathy. Neurology 2012;78(1 Suppl):P01.253
    PubMedGoogle Scholar
  • 147 So YT, Olney RK. Acute lumbosacral polyradiculopathy in acquired immunodeficiency syndrome: experience in 23 patients. Ann Neurol 1994; 35 (01) 53-58
    CrossrefPubMedGoogle Scholar
  • 148 Corral I, Quereda C, Casado JL. et al. Acute polyradiculopathies in HIV-infected patients. J Neurol 1997; 244 (08) 499-504
    CrossrefPubMedGoogle Scholar
  • 149 Talpos D, Tien RD, Hesselink JR. Magnetic resonance imaging of AIDS-related polyradiculopathy. Neurology 1991; 41 (12) 1995-1997
    CrossrefPubMedGoogle Scholar
  • 150 Wallis E, Al-Hakim B, Holmes P, Douthwaite S, Kulasegaram R. Avoiding a lumbar puncture may be a rash decision: a case report of varicella-zoster virus-associated radiculopathy in advanced HIV infection. Int J STD AIDS 2019; 30 (10) 1031-1033
    CrossrefPubMedGoogle Scholar
  • 151 Skripuletz T, Pars K, Schulte A. et al. Varicella zoster virus infections in neurological patients: a clinical study. BMC Infect Dis 2018; 18 (01) 238
    CrossrefPubMedGoogle Scholar
  • 152 Zubair AS, Hunt C, Watson J, Nelson A, Jones Jr LK. Imaging findings in patients with zoster-associated plexopathy. AJNR Am J Neuroradiol 2017; 38 (06) 1248-1251
    CrossrefPubMedGoogle Scholar
  • 153 Nelson A, Watson J, Reda H, Jones L. Zoster associated limb paresis (ZALP) is associated with prolonged weakness and pain: a natural history study. Neurology 2014; 82 (10) P6.107
    PubMedGoogle Scholar
  • 154 Lipson BK, Freeman WR, Beniz J. et al. Optic neuropathy associated with cryptococcal arachnoiditis in AIDS patients. Am J Ophthalmol 1989; 107 (05) 523-527
    CrossrefPubMedGoogle Scholar
  • 155 Garg RK, Malhotra HS, Kumar N, Uniyal R. Vision loss in tuberculous meningitis. J Neurol Sci 2017; 375: 27-34
    CrossrefPubMedGoogle Scholar
  • 156 Munro M, Yadavalli T, Fonteh C, Arfeen S, Lobo-Chan A-M. Cytomegalovirus retinitis in HIV and non-HIV individuals. Microorganisms 2019; 8 (01) 55
    CrossrefPubMedGoogle Scholar
  • 157 Biswas J, Choudhry S, Priya K, Gopal L. Detection of cytomegalovirus from vitreous humor in a patient with progressive outer retinal necrosis. Indian J Ophthalmol 2002; 50 (04) 319-321
    PubMedGoogle Scholar
  • 158 Cochrane TF, Silvestri G, McDowell C, Foot B, McAvoy CE. Acute retinal necrosis in the United Kingdom: results of a prospective surveillance study. Eye (Lond) 2012; 26 (03) 370-377 , quiz 378
    CrossrefPubMedGoogle Scholar
  • 159 Goldberg RA, Reichel E, Oshry LJ. Bilateral toxoplasmosis retinitis associated with ruxolitinib. N Engl J Med 2013; 369 (07) 681-683
    CrossrefPubMedGoogle Scholar
  • 160 Wu XN, Lightman S, Tomkins-Netzer O. Viral retinitis: diagnosis and management in the era of biologic immunosuppression: a review. Clin Exp Ophthalmol 2019; 47 (03) 381-395
    CrossrefPubMedGoogle Scholar
  • 161 Park KH, Bang JH, Park WB. et al. Retrobulbar optic neuritis and meningoencephalitis following progressive outer retinal necrosis due to CMV in a patient with AIDS. Infection 2008; 36 (05) 475-479
    CrossrefPubMedGoogle Scholar
  • 162 Long HM, Dick A. Presumed CMV associated necrotizing retinopathy in a non-HIV immunocompromised host. Clin Exp Ophthalmol 2005; 33 (03) 330-332
    CrossrefPubMedGoogle Scholar
  • 163 Engstrom Jr RE, Holland GN, Margolis TP. et al. The progressive outer retinal necrosis syndrome. A variant of necrotizing herpetic retinopathy in patients with AIDS. Ophthalmology 1994; 101 (09) 1488-1502
    CrossrefPubMedGoogle Scholar
  • 164 Brinkman K, Debast S, Sauerwein R, Ooyman F, Hiel J, Raemaekers J. Toxoplasma retinitis/encephalitis 9 months after allogeneic bone marrow transplantation. Bone Marrow Transplant 1998; 21 (06) 635-636
    CrossrefPubMedGoogle Scholar
  • 165 Nussenblatt RB, Belfort Jr R. Ocular toxoplasmosis. An old disease revisited. JAMA 1994; 271 (04) 304-307
    CrossrefPubMedGoogle Scholar
  • 166 Gagliuso DJ, Teich SA, Friedman AH, Orellana J. Ocular toxoplasmosis in AIDS patients. Trans Am Ophthalmol Soc 1990; 88: 63-86 , discussion 86–88
    PubMedGoogle Scholar
  • 167 Nagel MA, Bennett JL, Khmeleva N. et al. Multifocal VZV vasculopathy with temporal artery infection mimics giant cell arteritis. Neurology 2013; 80 (22) 2017-2021
    CrossrefPubMedGoogle Scholar
  • 168 Berger JR, Kaszovitz B, Post MJD, Dickinson G. Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases. Ann Intern Med 1987; 107 (01) 78-87
    CrossrefPubMedGoogle Scholar
  • 169 Yousry TA, Pelletier D, Cadavid D. et al. Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy. Ann Neurol 2012; 72 (05) 779-787
    CrossrefPubMedGoogle Scholar
  • 170 Carson KR, Evens AM, Richey EA. et al. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood 2009; 113 (20) 4834-4840
    CrossrefPubMedGoogle Scholar
  • 171 Carson KR, Focosi D, Major EO. et al. Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a review from the Research on Adverse Drug Events and Reports (RADAR) Project. Lancet Oncol 2009; 10 (08) 816-824
    CrossrefPubMedGoogle Scholar
  • 172 Sudhakar P, Bachman DM, Mark AS, Berger JR, Kedar S. Progressive multifocal leukoencephalopathy: recent advances and a neuro-ophthalmological review. J Neuroophthalmol 2015; 35 (03) 296-305
    CrossrefPubMedGoogle Scholar
  • 173 Tan CS, Koralnik IJ. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol 2010; 9 (04) 425-437
    CrossrefPubMedGoogle Scholar
  • 174 Horger M, Beschorner R, Beck R. et al. Common and uncommon imaging findings in progressive multifocal leukoencephalopathy (PML) with differential diagnostic considerations. Clin Neurol Neurosurg 2012; 114 (08) 1123-1130
    CrossrefPubMedGoogle Scholar
  • 175 Liman TG, Bohner G, Heuschmann PU, Endres M, Siebert E. The clinical and radiological spectrum of posterior reversible encephalopathy syndrome: the retrospective Berlin PRES study. J Neurol 2012; 259 (01) 155-164
    CrossrefPubMedGoogle Scholar
  • 176 Fugate JE, Rabinstein AA. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol 2015; 14 (09) 914-925
    CrossrefPubMedGoogle Scholar
  • 177 Feske SK. Posterior reversible encephalopathy syndrome: a review. Semin Neurol 2011; 31 (02) 202-215
    Article in Thieme ConnectPubMedGoogle Scholar
  • 178 Nightingale S, Wood C, Ainsworth J. The posterior reversible encephalopathy syndrome in HIV infection. BMJ Case Rep 2012; 2012: bcr0120125647
    CrossrefPubMedGoogle Scholar
  • 179 Bestetti A, Pierotti C, Terreni M. et al. Comparison of three nucleic acid amplification assays of cerebrospinal fluid for diagnosis of cytomegalovirus encephalitis. J Clin Microbiol 2001; 39 (03) 1148-1151
    CrossrefPubMedGoogle Scholar
  • 180 Zhang F, Tetali S, Wang XP, Kaplan MH, Cromme FV, Ginocchio CC. Detection of human cytomegalovirus pp67 late gene transcripts in cerebrospinal fluid of human immunodeficiency virus type 1-infected patients by nucleic acid sequence-based amplification. J Clin Microbiol 2000; 38 (05) 1920-1925
    CrossrefPubMedGoogle Scholar
  • 181 Lakeman FD, Whitley RJ. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. J Infect Dis 1995; 171 (04) 857-863
    CrossrefPubMedGoogle Scholar
  • 182 Whitley RJ. Herpes simplex virus infections of the central nervous system. Continuum (Minneap Minn) 2015; 21 (6 Neuroinfectious Disease): 1704-1713
    PubMedGoogle Scholar
  • 183 Cinque P, Vago L, Ceresa D. et al. Cerebrospinal fluid HIV-1 RNA levels: correlation with HIV encephalitis. AIDS 1998; 12 (04) 389-394
    CrossrefPubMedGoogle Scholar
  • 184 Plavina T, Subramanyam M, Bloomgren G. et al. Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy. Ann Neurol 2014; 76 (06) 802-812
    CrossrefPubMedGoogle Scholar
  • 185 Koralnik IJ, Boden D, Mai VX, Lord CI, Letvin NL. JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy. Neurology 1999; 52 (02) 253-260
    CrossrefPubMedGoogle Scholar
  • 186 Borges AS, Figueiredo JF. Detection of anti-Toxoplasma gondii IgG, IgM and IgA immunoglobulins in the serum, cerebrospinal fluid and saliva of patients with acquired immunodeficiency syndrome and neurotoxoplasmosis. Arq Neuropsiquiatr 2004; 62 (04) 1033-1037
    CrossrefPubMedGoogle Scholar
  • 187 Foy PC, van Burik J-AH, Weisdorf DJ. Galactomannan antigen enzyme-linked immunosorbent assay for diagnosis of invasive aspergillosis after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2007; 13 (04) 440-443
    CrossrefPubMedGoogle Scholar
  • 188 Onishi A, Sugiyama D, Kogata Y. et al. Diagnostic accuracy of serum 1,3-β-D-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis. J Clin Microbiol 2012; 50 (01) 7-15
    CrossrefPubMedGoogle Scholar
  • 189 Clifford DB, Arribas JR, Storch GA, Tourtellote W, Wippold FJ. Magnetic resonance brain imaging lacks sensitivity for AIDS associated cytomegalovirus encephalitis. J Neurovirol 1996; 2 (06) 397-403
    CrossrefPubMedGoogle Scholar
  • 190 Holland NRM, Power C, Mathews VP, Glass JD, Forman M, McArthur JCM. Cytomegalovirus encephalitis in acquired immunodeficiency syndrome (AIDS). Neurology 1994; 44 (3, Pt 1): 507-514
    CrossrefPubMedGoogle Scholar
  • 191 Sili U, Kaya A, Mert A. HSV Encephalitis Study Group. Herpes simplex virus encephalitis: clinical manifestations, diagnosis and outcome in 106 adult patients. J Clin Virol 2014; 60 (02) 112-118
    CrossrefPubMedGoogle Scholar
  • 192 Friedman DP, Flanders AE. MR imaging of BK virus encephalitis. AJNR Am J Neuroradiol 2006; 27 (05) 1016-1018
    PubMedGoogle Scholar
  • 193 Shah R, Bag AK, Chapman PR, Curé JK. Imaging manifestations of progressive multifocal leukoencephalopathy. Clin Radiol 2010; 65 (06) 431-439
    CrossrefPubMedGoogle Scholar
  • 194 Ashdown BC, Tien RD, Felsberg GJ. Aspergillosis of the brain and paranasal sinuses in immunocompromised patients: CT and MR imaging findings. AJR Am J Roentgenol 1994; 162 (01) 155-159
    CrossrefPubMedGoogle Scholar
  • 195 Levy RM, Mills CM, Posin JP, Moore SG, Rosenblum ML, Bredesen DE. The efficacy and clinical impact of brain imaging in neurologically symptomatic AIDS patients: a prospective CT/MRI study. J Acquir Immune Defic Syndr (1988) 1990; 3 (05) 461-471
    PubMedGoogle Scholar
  • 196 Cinque P, Scarpellini P, Vago L, Linde A, Lazzarin A. Diagnosis of central nervous system complications in HIV-infected patients: cerebrospinal fluid analysis by the polymerase chain reaction. AIDS 1997; 11 (01) 1-17
    CrossrefPubMedGoogle Scholar
  • 197 Datar S, Singh T, Rabinstein AA, Fugate JE, Hocker S. Long-term risk of seizures and epilepsy in patients with posterior reversible encephalopathy syndrome. Epilepsia 2015; 56 (04) 564-568
    CrossrefPubMedGoogle Scholar